TickerFacts.

A business in context

ALNY research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001178670-26-000062

  2. 8-K · Current report

    Report date 2026-07-30 · 0001178670-26-000060 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-06-01 · 0001178670-26-000048

  4. 4 · Ownership change

    Report date 2026-06-01 · 0001178670-26-000047

  5. 8-K · Current report

    Report date 2026-05-20 · 0001628280-26-038499 · Items 5.02,5.07

  6. 4 · Ownership change

    Report date 2026-05-20 · 0001178670-26-000042

  7. 4 · Ownership change

    Report date 2026-05-20 · 0001178670-26-000041

  8. 4 · Ownership change

    Report date 2026-05-20 · 0001178670-26-000040

  9. 4 · Ownership change

    Report date 2026-05-20 · 0001178670-26-000039

  10. 4 · Ownership change

    Report date 2026-05-20 · 0001178670-26-000038

  11. 4 · Ownership change

    Report date 2026-05-20 · 0001178670-26-000037

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-028605

  13. 8-K · Current report

    Report date 2026-04-30 · 0001628280-26-028601 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-05-20 · 0001628280-26-023923

  15. 8-K · Current report

    Report date 2026-03-02 · 0001628280-26-014728 · Items 5.02

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-007497

  17. 8-K · Current report

    Report date 2026-02-12 · 0001628280-26-007491 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-01-11 · 0001628280-26-001755 · Items 2.02

  19. 8-K · Current report

    Report date 2025-12-10 · 0001193125-25-315047 · Items 8.01,9.01

  20. 8-K · Current report

    Report date 2025-12-02 · 0001628280-25-055084 · Items 5.02

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-047345

  22. 8-K · Current report

    Report date 2025-10-30 · 0001628280-25-047342 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-09-30 · 0001193125-25-230201 · Items 1.01,2.03,9.01

  24. 8-K · Current report

    Report date 2025-09-12 · 0001193125-25-202366 · Items 1.01,2.03,3.02,8.01,9.01

  25. 8-K · Current report

    Report date 2025-09-08 · 0001193125-25-199686 · Items 8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001178670-25-000090

  27. 8-K · Current report

    Report date 2025-07-31 · 0001178670-25-000089 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-12 · 0001178670-25-000076 · Items 5.02

  29. 8-K · Current report

    Report date 2025-05-08 · 0001178670-25-000062 · Items 5.03,5.07

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001178670-25-000052

  31. 8-K · Current report

    Report date 2025-05-01 · 0001178670-25-000050 · Items 9.01

  32. DEF 14A · Proxy statement

    Report date 2025-05-08 · 0001178670-25-000040

  33. 8-K · Current report

    Report date 2025-03-20 · 0001178670-25-000038 · Items 8.01

  34. 8-K · Current report

    Report date 2025-03-03 · 0001178670-25-000031 · Items 5.02

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001178670-25-000026

  36. 8-K · Current report

    Report date 2025-02-13 · 0001178670-25-000020 · Items 9.01

  37. 8-K · Current report

    Report date 2025-01-12 · 0001178670-25-000008 · Items 2.02

  38. SC 13G/A · Ownership disclosure

    0000315066-24-002658

  39. SC 13G/A · Ownership disclosure

    0000902219-24-000383

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001178670-24-000053

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 19 transaction rows19SGrant / award: 19 transaction rows19AExercise / conversion: 4 transaction rows4MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

42 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-01
2026-06-03
PYOTT DAVID E I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1175.0298.91
2026-06-01
2026-06-03
PYOTT DAVID E I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock17.0302.65
2026-06-01
2026-06-03
PYOTT DAVID E I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock921.0297.71
2026-06-01
2026-06-03
PYOTT DAVID E I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock495.0300.72
2026-06-01
2026-06-03
PYOTT DAVID E I
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3830.00.0
2026-06-01
2026-06-03
PYOTT DAVID E I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1222.0299.87
2026-06-01
2026-06-03
PYOTT DAVID E I
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
3830.00.0
2026-06-01
2026-06-03
Cravatt BenjaminA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
4393.00.0
2026-05-20
2026-05-22
Sigal Charles ElliottA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
Sigal Charles ElliottA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-20
2026-05-22
SCHULMAN AMY WA · Grant / award
Acquired
Common Stock838.00.0
2026-05-20
2026-05-22
SCHULMAN AMY WA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1802.00.0
2026-05-20
2026-05-22
Reitan Colleen FA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
Reitan Colleen FA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-20
2026-05-22
PYOTT DAVID E IA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
PYOTT DAVID E IA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-20
2026-05-22
KELLOGG PETER NA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
KELLOGG PETER NA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-20
2026-05-22
HAMBURG MARGARET AA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
HAMBURG MARGARET AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-20
2026-05-22
BRANDICOURT OLIVIERA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
BRANDICOURT OLIVIERA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-20
2026-05-22
Ausiello Dennis AA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
Ausiello Dennis AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-20
2026-05-22
Arbuckle Stuart AA · Grant / award
Acquired
Common Stock671.00.0
2026-05-20
2026-05-22
Arbuckle Stuart AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1441.00.0
2026-05-13
2026-05-14
SCHULMAN AMY WM · Exercise / conversion
Acquired
Common Stock11250.070.2
2026-05-13
2026-05-14
SCHULMAN AMY WM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
11250.00.0
2026-04-06
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock199.0333.94
2026-04-06
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock293.0331.89
2026-04-06
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock829.0330.46
2026-04-06
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock909.0329.76
2026-04-06
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock56.0320.14
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock209.0318.47
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock265.0316.61
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock359.0317.44
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8.0325.49
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock81.0323.64
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock86.0319.69
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock224.0321.64
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock245.0322.86
2026-04-02
2026-04-07
McLaughlin Melissa
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock147.0320.62

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001178670ALNYLAM PHARMACEUTICALS, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
529900S3ZI14OWRJII50
GLEIF legal name
Alnylam Pharmaceuticals, Inc.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-07-02T13:58:02Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Alnylam Pharmaceuticals · alias · wikidata
  • Alnylam · alias · wikidata
  • ALNYLAM PHARMACEUTICALS INC · former SEC name · 2002-07-09 to 2004-07-02
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.25B$2.39B
2023-12-31$1.83B$2.00B
2022-12-31$1.04B$1.18B
2021-12-31$844.29M$1.04B
2020-12-31$492.85M$635.87M
2019-12-31$219.75M$287.00M
2018-12-31$74.91M$99.61M
2017-12-31$89.91M$122.48M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗